Everest to bring Canadian biotech's potential COVID shots to China, other markets


Source: newsbreak.com newsbreak.com

Key Topics in this News Article:

News Snapshot:

BEIJING, Sept 13 (Reuters) - Shanghai-based Everest Medicines (1952.HK) said it signed a licence agreement with Providence Therapeutics to make and sell the Canadian biotechnology company's potential mRNA COVID vaccines in some Asian countries including China. Interim data from an early-stage human trial outside China has showed Providence's shot PTX-COVID19-B was safe and produced strong antibody responses, Everest said in a statement on Monday. Messenger RNA (mRNA) vaccines prompt the body to make a protein that is part of the virus, triggering an immune response. Companies including Pfizer (PFE.N) and BioNTech , and Moderna (MRNA.O) use mRNA technology in their...